Search Results

HOME > SEARCH > SEARCH RESULTS

Refine by Audience:

Selected filters: Healthcare Provider

Displaying 51 to 60 of 246 records
Sort by: Page: << Prev 3… 4… 5… 6… 7… 8… 9… Next >>

SNMMI Submits Comments to CMS on Physician Fee Schedule and Hospital Outpatient Payments – Sep 20, 2023
Last week SNMMI and ACNM submitted comments to CMS on its proposed rules for the 2024 Physician Fee Schedule and Hospital Outpatient Prospective Payment System.
Nuclear Medicine Treatment Cures Lethal Form of Ovarian Cancer in Preclinical Setting – Sep 18, 2023
A new 225Ac-DOTA-based pre-targeted radioimmunotherapy system has been shown to cure a highly lethal form of advanced intraperitoneal ovarian cancer in a preclinical setting with minimal side effects, according to research published in JNM.
SNMMI Submits Comments to NRC on Patient Release, Injection Extravasations – Sep 7, 2023
SNMMI has submitted comments to the Nuclear Regulatory Commission (NRC) on several important issues: its draft regulatory guide on release of patients and its rulemaking on reporting of nuclear medicine injection extravasations as medical events.
JNM Publishes Consensus Statement on Patient Selection and Appropriate Use of Lu-177 PSMA-617 Radionuclide Therapy – Sep 1, 2023
SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with Lu-177 PSMA radionuclide therapy.
Journals – Aug 18, 2023
Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.
PSMA PET/CT Waives the Need for Pre-Imaging Biopsy in Elderly Patients – Aug 14, 2023
In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy, according to new research published in JNM.
SNMMI Announces Ones to Watch 2023 Selections – Aug 7, 2023
SNMMI is pleased to present our annual list of 30 early career professionals selected as Ones to Watch in 2023!
Clinical Trials Network – Aug 3, 2023
The SNMMI Clinical Trials Network provides tools and resources to promote faster, more cost-effective drug development and increase the availability and performance of molecular imaging radiopharmaceuticals for use in the clinic. Increased standardization in trials leads to better data that then results in expanded utilization of radiopharmaceuticals.
Advanced Associate Council – Jul 11, 2023
FDA Fully Approves Leqembi for Alzheimers; CMS Unclear on PET Reimbursement – Jul 10, 2023
The FDA has granted full approval to Leqembi (lecanemab); however, CMS has not committed to reimbursement of the needed PET scans.

Displaying 51 to 60 of 246 records
Page: << Prev 3… 4… 5… 6… 7… 8… 9… Next >>